BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4949164)

  • 1. Clinical experience with L-asparaginase.
    Hamilton-Fairley G; Malpas JS; Galton DA
    Recent Results Cancer Res; 1970; 33():257-62. PubMed ID: 4949164
    [No Abstract]   [Full Text] [Related]  

  • 2. Some clinical observations on the treatment with L-asparaginase of the acute leukemias.
    Marmont AM; Damasio EE
    Recent Results Cancer Res; 1970; 33():296-315. PubMed ID: 4949165
    [No Abstract]   [Full Text] [Related]  

  • 3. L-asparaginase in treatment of acute leukaemia and lymphosarcoma.
    Beard ME; Crowther D; Galton DA; Guyer RJ; Fairley GH; Kay HE; Knapton PJ; Malpas JS; Scott RB
    Br Med J; 1970 Jan; 1(5690):191-5. PubMed ID: 4904933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 5. [First results of the treatment of acute leukemia with L-asparaginase].
    Marmont A; Damasio E; Bordo D; Fazio F; Gori E; Rossi F
    Haematologica; 1970; 55(9):593-6. PubMed ID: 4996527
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro test for sensitivity of leukemic cells to L-asparaginase.
    Schrek R; Dolowy WC
    Cancer Res; 1971 May; 31(5):523-6. PubMed ID: 4932205
    [No Abstract]   [Full Text] [Related]  

  • 7. L-asparaginase and human malignant disease.
    Crowther D
    Nature; 1971 Jan; 229(5281):168-71. PubMed ID: 4923259
    [No Abstract]   [Full Text] [Related]  

  • 8. The place of the L-asparaginase in the treatment of acute leukemias.
    Mathé G; Amiel JL; Clarysse A; Hayat M; Schwarzenberg L
    Recent Results Cancer Res; 1970; 33():278-87. PubMed ID: 4403337
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
    Kondrat'eva NA; Lorie IlI ; Kruglova GV; Vorob'ev AI; Koshel' IV
    Antibiotiki; 1977 Sep; 22(9):852-7. PubMed ID: 334060
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
    Clarkson B; Krakoff I; Burchenal J; Karnofsky D; Golbey R; Dowling M; Oettgen H; Lipton A
    Cancer; 1970 Feb; 25(2):279-305. PubMed ID: 4905154
    [No Abstract]   [Full Text] [Related]  

  • 11. Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli.
    Ohnuma T; Holland JF; Meyer P
    Cancer; 1972 Aug; 30(2):376-81. PubMed ID: 4559405
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.
    Pratt CB; Simone JV; Zee P; Aur RJ; Johnson WW
    J Pediatr; 1970 Sep; 77(3):474-83. PubMed ID: 5278225
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of leukemias in man by L-asparaginase.
    Oettgen HF; Old LJ; Boyse EA; Campbell HA; Philips FS; Clarkson BD; Tallal L; Leeper RD; Schwartz MK; Kim JH
    Cancer Res; 1967 Dec; 27(12):2619-31. PubMed ID: 5237354
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase.
    King OY; Wilbur JR; Mumford DM; Sutow WW
    Cancer; 1974 Mar; 33(3):611-4. PubMed ID: 4592901
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials of asparaginase in chemotherapy-resistant acute leukemias.
    Goudemand M; Bauters F
    Recent Results Cancer Res; 1970; 33():316-22. PubMed ID: 5292721
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of leukemia in USA. 2. L asparaginase in leukemia].
    Böttiger LE
    Lakartidningen; 1969 Jan; 66(5):455-60. PubMed ID: 5254602
    [No Abstract]   [Full Text] [Related]  

  • 17. Dysmetabolic and neurological complications in leukemia patients treated with L-asparaginase.
    Storti E; Quaglino D
    Recent Results Cancer Res; 1970; 33():344-9. PubMed ID: 5292723
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with L-asparaginase.
    Carbone PP; Haskell CM; Leventhal BG; Block JB; Selawry OS
    Recent Results Cancer Res; 1970; 33():236-43. PubMed ID: 4949163
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical experience with L-asparaginase.
    Oettgen HF; Tallal L; Tan CC; Murphy ML; Clarkson BD; Golbey RD; Krakoff IH; Karnofsky DA; Burchenal HJ
    Recent Results Cancer Res; 1970; 33():219-35. PubMed ID: 5292718
    [No Abstract]   [Full Text] [Related]  

  • 20. Favorable remission induction rate with twice weekly doses of L-asparaginase.
    Jaffe N; Traggis D; Das L; Frauenberger G; Hann HW; Kim BS; Bishop Y
    Cancer Res; 1973 Jan; 33(1):1-4. PubMed ID: 4565907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.